Online AthensUGA research looks at stem cells to help stroke patientsOnline AthensThe research team led by UGA professor Steven Stice and Nasrul Hoda of Augusta University created a treatment called AB126 using extracellular vesicles, fluid-filled stru… Continue reading
Nasdaq |
FDA clears AstraZeneca’s lung cancer immunotherapy
PharmaLive (press release) (Reuters) – The U.S. Food and Drug Administration on Friday granted approval for expanded use of AstraZeneca Plc’s, immunotherapy drug, Imfinzi, to treat non-small cell lung cancer whose tumors can’t be surgically removed. The approval was based on a … U.S. FDA approves AstraZeneca’s immunotherapy for lung cancer …Nasdaq US FDA approves AstraZeneca’s immunotherapy for lung cancerBusiness Insider |
KRQE News 13 |
Can gene therapy be harnessed to fight the AIDS virus?
KRQE News 13 “Gene therapy techniques have advanced greatly,” said Dr. Otto Yang of the UCLA AIDS Institute, one place working on this. “A lot of people are thinking it’s the right time to go back.” They include Dr. Anthony Fauci, director of the National Institute … |
Madison.com |
How Celgene Hopes to Cash In on CAR–T
Madison.com Chimeric antigen T–cell therapy (CAR-T) is an important new approach to battling blood cancer, and while it’s too soon to say what company will develop an approved treatment first, Celgene (NASDAQ: CELG) has a good shot at coming out on top. In January … |
|
How Celgene Hopes to Cash In on CAR–T
Motley Fool Chimeric antigen T–cell therapy (CAR-T) is an important new approach to battling blood cancer, and while it’s too soon to say what company will develop an approved treatment first, Celgene (NASDAQ:CELG) has a good shot at coming out on top. In January … |
|
How Celgene Hopes to Cash In on CAR–T
Motley Fool Chimeric antigen T–cell therapy (CAR-T) is an important new approach to battling blood cancer, and while it’s too soon to say what company will develop an approved treatment first, Celgene (NASDAQ:CELG) has a good shot at coming out on top. In January … |